274 related articles for article (PubMed ID: 11211063)
1. A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome.
Kayumov L; Brown G; Jindal R; Buttoo K; Shapiro CM
Psychosom Med; 2001; 63(1):40-8. PubMed ID: 11211063
[TBL] [Abstract][Full Text] [Related]
2. Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study.
Eckerberg B; Lowden A; Nagai R; Akerstedt T
Chronobiol Int; 2012 Nov; 29(9):1239-48. PubMed ID: 23005039
[TBL] [Abstract][Full Text] [Related]
3. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.
Chang YS; Lin MH; Lee JH; Lee PL; Dai YS; Chu KH; Sun C; Lin YT; Wang LC; Yu HH; Yang YH; Chen CA; Wan KS; Chiang BL
JAMA Pediatr; 2016 Jan; 170(1):35-42. PubMed ID: 26569624
[TBL] [Abstract][Full Text] [Related]
4. Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study.
Jain SV; Horn PS; Simakajornboon N; Beebe DW; Holland K; Byars AW; Glauser TA
Sleep Med; 2015 May; 16(5):637-44. PubMed ID: 25862116
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
Zemlan FP; Mulchahey JJ; Scharf MB; Mayleben DW; Rosenberg R; Lankford A
J Clin Psychiatry; 2005 Mar; 66(3):384-90. PubMed ID: 15766306
[TBL] [Abstract][Full Text] [Related]
6. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
Wasdell MB; Jan JE; Bomben MM; Freeman RD; Rietveld WJ; Tai J; Hamilton D; Weiss MD
J Pineal Res; 2008 Jan; 44(1):57-64. PubMed ID: 18078449
[TBL] [Abstract][Full Text] [Related]
7. The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study.
MacFarlane JG; Cleghorn JM; Brown GM; Streiner DL
Biol Psychiatry; 1991 Aug; 30(4):371-6. PubMed ID: 1912128
[TBL] [Abstract][Full Text] [Related]
8. Entrainment of free-running circadian rhythms by melatonin in blind people.
Sack RL; Brandes RW; Kendall AR; Lewy AJ
N Engl J Med; 2000 Oct; 343(15):1070-7. PubMed ID: 11027741
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial with bright light and melatonin for the treatment of delayed sleep phase disorder: effects on subjective and objective sleepiness and cognitive function.
Wilhelmsen-Langeland A; Saxvig IW; Pallesen S; Nordhus IH; Vedaa Ø; Lundervold AJ; Bjorvatn B
J Biol Rhythms; 2013 Oct; 28(5):306-21. PubMed ID: 24132057
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
[TBL] [Abstract][Full Text] [Related]
11. Improvement of sleep quality in elderly people by controlled-release melatonin.
Garfinkel D; Laudon M; Nof D; Zisapel N
Lancet; 1995 Aug; 346(8974):541-4. PubMed ID: 7658780
[TBL] [Abstract][Full Text] [Related]
12. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
[TBL] [Abstract][Full Text] [Related]
13. Predictors of subjective sleepiness induced by melatonin administration.
Jean-Louis G; von Gizycki H; Zizi F
J Psychosom Res; 1999 Oct; 47(4):355-8. PubMed ID: 10616229
[TBL] [Abstract][Full Text] [Related]
14. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
Hughes RJ; Sack RL; Lewy AJ
Sleep; 1998; 21(1):52-68. PubMed ID: 9485533
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
Maras A; Schroder CM; Malow BA; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):699-710. PubMed ID: 30132686
[No Abstract] [Full Text] [Related]
16. Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs.
Dawson D; Rogers NL; van den Heuvel CJ; Kennaway DJ; Lushington K
J Biol Rhythms; 1998 Dec; 13(6):532-8. PubMed ID: 9850013
[TBL] [Abstract][Full Text] [Related]
17. Melatonin in patients with reduced REM sleep duration: two randomized controlled trials.
Kunz D; Mahlberg R; Müller C; Tilmann A; Bes F
J Clin Endocrinol Metab; 2004 Jan; 89(1):128-34. PubMed ID: 14715839
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant action of melatonin in the treatment of Delayed Sleep Phase Syndrome.
Rahman SA; Kayumov L; Shapiro CM
Sleep Med; 2010 Feb; 11(2):131-6. PubMed ID: 20044310
[TBL] [Abstract][Full Text] [Related]
19. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
Roth T; Seiden D; Wang-Weigand S; Zhang J
Curr Med Res Opin; 2007 May; 23(5):1005-14. PubMed ID: 17519067
[TBL] [Abstract][Full Text] [Related]
20. Daytime melatonin administration in elderly good and poor sleepers: effects on core body temperature and sleep latency.
Lushington K; Pollard K; Lack L; Kennaway DJ; Dawson D
Sleep; 1997 Dec; 20(12):1135-44. PubMed ID: 9493923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
